Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.20.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Total
Beginning balance at Dec. 31, 2018 $ 479,000 $ 543,754,000 $ (410,188,000) $ 134,045,000
Beginning balance, shares at Dec. 31, 2018 47,944,486        
Stock option-based compensation expense 2,103,000 2,103,000
Restricted stock-based compensation expense 172,000 172,000
Common stock issued for cash exercise of options 28,000 28,000
Common stock issued for cash exercise of options, shares 5,208        
Net loss (18,555,000) (18,555,000)
Other comprehensive income
Ending balance at Mar. 31, 2019 $ 479,000 546,057,000 (428,743,000) 117,793,000
Ending balance, shares at Mar. 31, 2019 47,949,694        
Beginning balance at Dec. 31, 2019 $ 836,000 664,064,000 (486,470,000) 178,430,000
Beginning balance, shares at Dec. 31, 2019 83,622,135        
Stock option-based compensation expense 1,256,000 1,256,000
Restricted stock-based compensation expense 464,000 464,000
Net loss (48,159,000) (48,159,000)
Other comprehensive income 386,000 386,000
Ending balance at Mar. 31, 2020 $ 836,000 $ 665,784,000 $ (534,629,000) $ 386,000 $ 132,377,000
Ending balance, shares at Mar. 31, 2020 83,622,135